Innocan Pharma Corp. buy Maxi_Scalibusa
Start price
23.01.21
/
50%
€0.31
Target price
23.01.22
€6.00
Performance (%)
33.11%
End price
24.01.22
€0.41
Summary
This prediction ended on 24.01.22 with a price of €0.41. The BUY prediction by Maxi_Scalibusa for Innocan Pharma Corp. saw massive gains of 33.11%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Innocan Pharma Corp. | - | - | - | - |
iShares Core DAX® | 1.560% | 2.566% | 18.261% | 16.927% |
iShares Nasdaq 100 | 0.517% | 1.894% | 25.521% | 35.441% |
iShares Nikkei 225® | 1.730% | 5.631% | 18.569% | 13.063% |
iShares S&P 500 | 1.482% | 1.594% | 24.989% | 38.339% |
According to Maxi_Scalibusa what are the pros and cons of Innocan Pharma Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Maxi_Scalibusa for this prediction
In the thread Innocan Pharma Corp. diskutieren
Buy mit Kursziel 6,0
In the thread Trading Innocan Pharma Corp.
Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten